Heart study aims to ditch problematic drug for stent checks
NCT ID NCT06273293
Summary
This study is testing a new, simpler way to measure blood flow in heart arteries after a stent procedure for patients with multiple blockages. The goal is to see if using a common heart medication (nitroglycerin) instead of a drug that can cause side effects (adenosine) gives equally good results. Researchers will follow 150 patients for one year to see if the new measurement method can predict future heart problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Juan Ramón Jiménez
RECRUITINGHuelva, 21005, Spain
-
Hospital Universitario San Juan de Alicante
RECRUITINGAlicante, 03550, Spain
-
Hospital Universitario Virgen del Rocío
RECRUITINGSeville, 41013, Spain
-
Hospital Universitario de Badajoz
RECRUITINGBadajoz, 06080, Spain
Conditions
Explore the condition pages connected to this study.